Redefining Blood Pressure Targets in High-Risk Patients?: Lessons From Coronary Endpoints in Recent Randomized Clinical Trials

Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes

(2011) Hermann Haller et al.   NEW ENGLAND JOURNAL OF MEDICINE

What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes?

(2010) Sripal Bangalore et al.   CIRCULATION

J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial

(2010) S. Bangalore et al.   EUROPEAN HEART JOURNAL

Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly

(2010) Toshio Ogihara et al.   HYPERTENSION

Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document

(2009) Giuseppe Mancia et al.   BLOOD PRESSURE

Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension

(2009) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal

(2009) Alberto Zanchetti et al.   JOURNAL OF HYPERTENSION

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

(2009) Peter Sleight et al.   JOURNAL OF HYPERTENSION

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Treatment of Hypertension in Patients 80 Years of Age or Older

(2008) Nigel S. Beckett et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

(2008) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE